Bottom line
Is STXD a good fund? The bottom line
STXD is an actively managed dividend & equity income ETF from ARK Invest.
Annual fees run 0.35% — about $35 a year on every $10,000 invested, cheaper than 87% of dividend & equity income funds we track.
It returned +14.7% over one year (as of Dec 31, 2025, per its prospectus).
With $67.2 million in net assets and 179 holdings, its largest position is Eli Lilly & Co (5.9%) and the top 10 make up 39.8% of the portfolio.
The closest lower-cost alternative we found is VIG (0.04%, 54% top-holdings overlap).
What stands out
- Low cost: cheaper than 87% of dividend & equity income peers
Updated Nov 19, 2026
What STXD invests in
The Strive 1000 Dividend Growth ETF (the Fund) seeks to track the total return performance, before fees and expenses, of an index composed of U.S.-listed equities with a history of consistently growing dividends.
The Funds Investment Strategy The Fund seeks to track the investment results of the Bloomberg U.S. 1000 Dividend Growth Index (the Index). The Index is a subset of the Bloomberg U.S. 1000 Growth Index, which measures the performance of large- and mid-capitalization growth companies in the U.S. equity market as determined by Bloomberg. Under normal circumstances, the Fund invests at least 80% of its net assets (plus any borrowings for investment purposes) in dividend paying equity securities. The Fund defines dividend paying equity securities as companies that have i) demonstrated five consecutive years of positive dividend growth and ii) exhibits a five year-dividend growth ratio that is greater than the overall Bloomberg U.S. 1000 Growth Index (Dividend Paying Companies). The Index will generally consist of approximately 200 constituents. The Index may have significant exposure to…
From the fund's prospectus (filed Oct 28, 2026).
STXD performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| STXD | +14.7% | — | — |
| Dividend & Equity Income median | +14.6% | +10.1% | +9.2% |
Source: Fund prospectus, as of Dec 31, 2025
What STXD costs
On a $10,000 investment, STXD's 0.35% expense ratio costs about $35 a year. The prospectus estimates $443 in total costs over 10 years (assuming 5% annual returns). The median dividend & equity income fund charges 0.74%.
STXD top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Eli Lilly & Co LLY | 5.89% |
| 2 | Broadcom Inc AVGO | 5.23% |
| 3 | Jpmorgan Chase & Co. JPM | 5.04% |
| 4 | Microsoft Corp MSFT | 4.36% |
| 5 | Visa Inc V | 3.81% |
| 6 | Applied Materials Inc AMAT | 3.78% |
| 7 | Lam Research Corp LRCX | 3.57% |
| 8 | Mastercard Inc MA | 2.77% |
| 9 | Costco Wholesale Corp COST | 2.75% |
| 10 | Kla Corp KLAC | 2.62% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 39.8% of the fund. See all top 25 holdings and asset mix →